Gilead Sciences CEO on FDA approval of Yeztugo: A milestone moment in the history of HIV

Gilead CEO Daniel O'Day on new HIV prevention medicine: It's going to change the face of HIV

Gilead Sciences CEO Daniel O'Day Remarks at 2019 World AIDS Day Observances

Daniel O’Day of Gilead Sciences, Inc. on COVID-19 Efforts

Darwin Thompson, Richard Daniels, and Daniel O'Day at SAGE Gala 2022

Daniel O'Day

Gilead CEO Daniel O'Day on remdesivir pricing and ensuring access to treatment